Embryoxite is developing an AI bioplatform to customize the clinical diagnosis and embryo selection in assisted reproduction treatments using the embryo’s biological, clinical, genetic, metabolic, and morphokinetic information. Our goal is to increase the pregnancy probability for an IVF treatment by 75% Sectors Biotechnology and medical research Location Buenos Aires, Argentina Stage Sign in to view details Markets Sign in to view details Customer model Sign in to view details Contact Sign in to view details Social media